(R)-3-氨基丁酸甲酯 | 6078-06-4

• 物质功能分类: 化学试剂 - 有机试剂 - 酯类
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: (R)-3-氨基丁酸甲酯
• 中文别名: R-3-氨基丁酸甲酯
• 英文名称: methyl 3-aminobutyrate
• 英文别名: methyl 3-aminobutanoate；methyl 3-amino-3-methylpropionate
• CAS: 6078-06-4
• 化学式: C₅H₁₁NO₂
• mdl: MFCD08444149
• 分子量: 117.148
• InChiKey: SJQZRROQIBFBPS-UHFFFAOYSA-N

物化性质

• 沸点：
  54-55 °C(Press: 13 Torr)
• 密度：
  0.993 g/cm3

计算性质

• 辛醇/水分配系数(LogP)：
  -0.5
• 重原子数：
  8
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  52.3
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2922499990

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Methyl 3-aminobutanoate
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Methyl 3-aminobutanoate
CAS number: 6078-06-4

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C5H11NO2
Molecular weight: 117.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  (R)-3-氨基丁酸甲酯 在 亚硝酸 作用下， 生成 (R)-3-羟基丁酸
  参考文献：
  名称：

  Fischer,E.; Scheibler, Justus Liebigs Annalen der Chemie, 1911, vol. 383, p. 343

  摘要：

  DOI：
• 作为产物：
  描述：

  Methyl 3-aminobutyrate p-toluenesulfonate salt 在 氨 作用下， 以 乙醚 为溶剂， 生成 (R)-3-氨基丁酸甲酯
  参考文献：
  名称：

  Liou, Lara R.; McNeil, Anne J.; Toombes, Gilman E. S., Journal of the American Chemical Society, 2008, vol. 130, p. 17334 - 17341

  摘要：

  DOI：

文献信息

• [EN] 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE LA 3-PHOSPHOGLYCÉRATE DÉSHYDROGÉNASE ET LEURS UTILISATIONS
  申请人：RAZE THERAPEUTICS INC

  公开号：WO2017156181A1

  公开（公告）日：2017-09-14

  The present invention provides compounds, compositions thereof, and methods of using the same.

  本发明提供了化合物、其组合物以及使用这些化合物的方法。
• Direct Synthesis of α-Amino Nitriles from Sulfonamides via Base-Mediated C–H Cyanation
  作者：Shasha Shi、Xianyu Yang、Man Tang、Jiefeng Hu、Teck-Peng Loh

  DOI：10.1021/acs.orglett.1c01232

  日期：2021.5.21

  Herein, we disclose a transition-metal-free reaction system that enables α-cyanation of sulfonamides through C–H bond cleavage for the preparation of α-amino nitriles, including difficult-to-access all-alkyl α-tertiary scaffolds. More than 50 substrate examples prove a wide functional group tolerance. Additionally, its synthetic practicality is highlighted by gram-scalability and the late-stage modification

  在这里，我们公开了一种无过渡金属的反应体系，该体系可使磺酰胺通过C–H键断裂进行α-氰化，以制备α-氨基腈，包括难以接近的全烷基α-叔骨架。超过50个底物实例证明了广泛的官能团耐受性。另外，其合成实用性通过克可缩放性和天然化合物的后期修饰得到突出。机理实验表明，该过程涉及通过碱促进的HF的消除而原位形成亚胺中间体。
• Synthesis and evaluation of chiral β-amino acid-based low-molecular-weight organogelators possessing a methyl/trifluoromethyl side chain
  作者：Koichi Kodama、Ryuta Kawamata、Takuji Hirose

  DOI：10.1039/c8nj05668d

  日期：——

  The synthesis and gelation properties of chiral β-amino acid-based low-molecular-weight organogelators, possessing methyl/trifluoromethyl side chains, are reported. The structure of the side chain and chirality were found to be important parameters affecting the gelation ability. The pure enantiomer of the trifluoromethylated β-amino acid displayed good gelation properties due to the formation of fibrillar

  报道了具有甲基/三氟甲基侧链的基​​于手性β-氨基酸的低分子量有机胶凝剂的合成和胶凝特性。发现侧链的结构和手性是影响胶凝能力的重要参数。三氟甲基化的β-氨基酸的纯对映体由于增强的酰胺氢键的驱动而形成了纤维状网络，因此显示出良好的胶凝特性。对烷基链长度影响的研究表明，更长的烷基链可改善胶凝能力，但在所有分子中均观察到相同的超分子结构，并且在熔点和T g值上均具有奇偶效应。
• Design and synthesis of a series of indole glycoprotein IIb/IIIa inhibitors
  作者：Valérie Grumel、Jean-Yves Mérour、Brigitte Lesur、Thierry Giboulot、Armand Frydman、Gérald Guillaumet

  DOI：10.1016/s0223-5234(01)01325-3

  日期：2002.1

  Synthesis of 1,3-disubstituted indoles derivatives as potential glycoprotein (GP) IIb/IIIa antagonists was reported. Substitution of the indolic nitrogen atom by piperidino or benzamidino moieties was used as mimics of an arginine residue. The acid carboxylic group was linked to the indole scaffold in position-3 via a methylene unit (compounds 4, 9, 10). Introduction of a beta-alanine chain was carried

  报道了作为潜在糖蛋白（GP）IIb / IIIa拮抗剂的1,3-二取代吲哚衍生物的合成。哌啶子基或苯甲mid基部分取代吲哚氮原子用作精氨酸残基的模拟物。酸性羧酸基团通过亚甲基单元（化合物4、9、10）连接到位置3的吲哚骨架上。在酸（17-22）上引入β-丙氨酸链，所述酸在脱保护和碱性水解后得到最终化合物39-46。吲哚支架与酰胺键之间的距离从无亚甲基单元（化合物39）调整为1（化合物40、41）或2个亚甲基单元（化合物42-46）。β-丙氨酸链上的甲苯磺酰基氨基（化合物56）的存在会稍微增加对胶原蛋白引发的血小板凝集的抑制作用。
• MACROCYCLIC COMPOUND AS CDK INHIBITOR, PREPARATION METHOD THEREFOR, AND USE THEREOF IN MEDICINE
  申请人：Keythera (Suzhou) Pharmaceuticals Co. Ltd.

  公开号：EP3865488A1

  公开（公告）日：2021-08-18

  The present invention relates to a macrocyclic compound as a CDK inhibitor, a preparation method therefor and the use thereof in medicine. Specifically, the present invention relates to a novel macrocyclic compound represented by a general formula (I), a preparation method therefor, a pharmaceutical composition containing the compound, the use thereof as a therapeutic agent, particularly as a CDK inhibitor, and the use thereof in treating cancers, inflammation, viral infections, cardiac hypertrophy or HIV, wherein each substituent of the general formula (I) is the same as that defined in the description.

  本发明涉及一种巨环化合物作为CDK抑制剂，其制备方法及在医学上的应用。具体地，本发明涉及一种由通式（I）表示的新型巨环化合物，其制备方法，含有该化合物的药物组合物，其作为治疗剂的用途，特别是作为CDK抑制剂的用途，以及其在治疗癌症、炎症、病毒感染、心脏肥大或HIV方面的用途，其中通式（I）的每个取代基与描述中定义的相同。